000 | 01709 a2200505 4500 | ||
---|---|---|---|
005 | 20250514213037.0 | ||
264 | 0 | _c20050217 | |
008 | 200502s 0 0 eng d | ||
022 | _a1108-7161 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLi, M | |
245 | 0 | 0 |
_aAlfacalcidol prevents age-related bone loss and causes an atypical pattern of bone formation in aged male rats. _h[electronic resource] |
260 |
_bJournal of musculoskeletal & neuronal interactions _cMar 2004 |
||
300 |
_a22-32 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAging _xpathology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBiomechanical Phenomena |
650 | 0 | 4 |
_aBone Density _xdrug effects |
650 | 0 | 4 |
_aBone Resorption _xdrug therapy |
650 | 0 | 4 |
_aBone and Bones _xdrug effects |
650 | 0 | 4 |
_aCalcification, Physiologic _xdrug effects |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aHydroxycholecalciferols _xpharmacology |
650 | 0 | 4 |
_aLumbar Vertebrae _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aOsteogenesis _xdrug effects |
650 | 0 | 4 |
_aOsteoporosis _xdrug therapy |
650 | 0 | 4 |
_aPeriosteum _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aTestosterone _xblood |
650 | 0 | 4 |
_aTibia _xdrug effects |
650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
650 | 0 | 4 |
_aWeight-Bearing _xphysiology |
700 | 1 | _aHealy, D R | |
700 | 1 | _aLi, Y | |
700 | 1 | _aSimmons, H A | |
700 | 1 | _aSu, M | |
700 | 1 | _aJee, W S S | |
700 | 1 | _aShen, V W | |
700 | 1 | _aThompson, D D | |
773 | 0 |
_tJournal of musculoskeletal & neuronal interactions _gvol. 4 _gno. 1 _gp. 22-32 |
|
999 |
_c15296491 _d15296491 |